Clinical Trials for Inovio Pharmaceuticals

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Inovio Pharmaceuticals

Clinical Trials (4)

NCT05293249
dMAbs for Prevention of COVID-19
PHASE1Active, not recruiting
61 participants
Started: May 19, 2022 · Completed: Dec 31, 2025
1 condition4 sponsors1 location
NCT04367675
INO 5401 Vaccination in BRCA1/2 Mutation Carriers
PHASE1Active, not recruiting
44 participants
Started: Apr 20, 2021 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT03491683
INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)
PHASE1/PHASE2Active, not recruiting
52 participants
Started: May 31, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor21 locations
NCT02772003
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection
PHASE1Active, not recruiting
33 participants
Started: Jun 6, 2016 · Completed: Mar 6, 2026
3 conditions2 sponsors5 locations